Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Kimball JenniferChief Accounting Officer | Grant or award · 10b5-1 plan | A | — 893 sh | Mar 18, 2026 |
| 0 | Sumner CrystalSee Remarks | Grant or award · 10b5-1 plan | A | — 693.8K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Sumner CrystalSee Remarks | Grant or award · 10b5-1 plan | A | — 297.3K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | $98K 9,204 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | — 40.0K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Rishel JeremyChief Technology Officer | Option exercise · 10b5-1 plan | M | — 28.7K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Fruge Mary CelesteVP, General Counsel | Option exercise · 10b5-1 plan | M | — 1,000 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Fruge Mary CelesteVP, General Counsel | Option exercise · 10b5-1 plan | M | $4,320 1,000 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | — 5,992 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | — 10.0K sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | — 9,204 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Tax withholding · 10b5-1 plan | F | $14K 87 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $280K 1,567 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Rishel JeremyChief Technology Officer | Option exercise · 10b5-1 plan | M | — 28.7K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | $107K 10.0K sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Option exercise · 10b5-1 plan | M | — 310 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Grant or award · 10b5-1 plan | A | — 2,679 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $260K 1,456 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Option exercise · 10b5-1 plan | M | — 295 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Tax withholding · 10b5-1 plan | F | $14K 91 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 44 | Deslarzes Jean-ChristopheDirector | Open-market purchase | BUY | $41K 1,665 sh | Mar 17, 2026 traded Mar 2, 2026 |
| 39 | Valentine CurtisChief Financial Officer | Open-market sale | SELL | $183K 2,268 sh | Mar 17, 2026 traded Mar 16, 2026 |
| 33 | Fazel PayvandSenior Vice President | Open-market sale | SELL | $212K 2,898 sh | Mar 17, 2026 traded Mar 13, 2026 |
| 31 | Rovinsky ZacharyChief Financial Officer | Grant or award | A | — 25.0K sh | Mar 17, 2026 traded Feb 17, 2026 |
| 30 | Reuter James ADirector, President and CEO | Grant or award | A | $1.04M 31.4K sh | Mar 17, 2026 traded Mar 15, 2026 |
| 30 | Jergensen JoshuaPresident & COO | Open-market sale | SELL | $1.25M 36.3K sh | Mar 17, 2026 traded Mar 13, 2026 |
| 29 | Ball Robert JosephDirector, CEO & Executive Chairman | Open-market purchase | BUY | $33K 2,200 sh | Mar 17, 2026 traded Mar 13, 2026 |
| 27 | Lieberman Elizabeth AEVP, Chief HR Officer | Grant or award | A | $309K 2,448 sh | Mar 17, 2026 traded Mar 13, 2026 |
| 27 | Blechman MichaelDirector | Grant or award | A | — 20.0K sh | Mar 17, 2026 traded Feb 17, 2026 |
| 27 | Blechman MichaelDirector | Grant or award | A | — 24.0K sh | Mar 17, 2026 traded Feb 17, 2026 |
| 26 | Trizzino PeterPresident, Global Sales | Tax withholding | F | $2.27M 15.0K sh | Mar 17, 2026 traded Mar 15, 2026 |
| 25 | Seger Andrew MDirector | Open-market purchase | BUY | $2,100 52 sh | Mar 17, 2026 traded Mar 17, 2026 |
| 24 | Schmidt Michael ReedDirector | Grant or award | A | — 34.0K sh | Mar 17, 2026 traded Sep 26, 2025 |
| 24 | Bender Bradley DChief Risk Officer | Tax withholding | F | $70K 1,594 sh | Mar 17, 2026 traded Mar 13, 2026 |
| 24 | Claypoole Robert EDirector, President and CEO | Grant or award | A | — 153.0K sh | Mar 17, 2026 traded Mar 14, 2025 |
| 24 | Bender Bradley DChief Risk Officer | Tax withholding | F | $101K 2,306 sh | Mar 17, 2026 traded Mar 13, 2026 |
| 24 | Claypoole Robert EDirector, President and CEO | Grant or award | A | — 134.0K sh | Mar 17, 2026 traded Mar 14, 2025 |
| 24 | Shepler Christopher L.Chief Banking Officer | Grant or award | A | $198K 5,971 sh | Mar 17, 2026 traded Mar 15, 2026 |
| 24 | Krasne Robert MorrisDirector | Grant or award | A | $58K 895 sh | Mar 17, 2026 traded Mar 16, 2026 |
| 24 | Coler ThomasEVP, CFO | Tax withholding | F | $64K 541 sh | Mar 17, 2026 traded Mar 15, 2026 |